Journals / Turkish Journal of Analytical Chemistry / 2022 / Cilt: 4 - Sayı: 2

Development and validation of RPLC method for the simultaneous analysis of ACE inhibitors in tablet formulations

Pages
103–110
Publication Date
2022-12-29
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

When deciding on these parameters, few experiments were carried out.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hypertension is a disease that can progress for many years without symptoms or complications.
📊
Key Findings & Data:However, when hypertension is treated effectively, these risk factors may decrease significantly.
💡
Conclusion & Impact:When deciding on these parameters, few experiments were carried out.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Hypertension · ACE inhibitors · RPLC

Abstract

Hypertension is a disease that can progress for many years without symptoms or complications. This disease can cause death and permanent damage to vital organs such as the kidney, heart, and brain. However, when hypertension is treated effectively, these risk factors may decrease significantly. Although many antihypertensive drugs are used in the treatment of hypertension, ACE inhibitors are a new class among these drugs, and their separation and quantitative determinations are important for the success of preclinical, biopharmaceutical, and clinical studies. For this reason, in this study, the simultaneous determination of cilazapril, benazepril, and quinapril from ACE inhibitors, the validation of the developed method, and the quantitative determination of commercial drug dosage forms are aimed. To obtain the optimum liquid chromatographic separation condition, a systematic approach based on the relationship between mobile phase pH and retention time was used. The mobile phase organic modified concentration and column temperature parameters, which are known to affect the retention times of the compounds, were kept constant. When deciding on these parameters, few experiments were carried out.

🔖

Cite This Article

KUZUCANLI, E., DEMİRALAY, E. Ç., DALDAL, Y. D., ÜSTÜN, Z., KONÇE, İ., ALSANCAK, A. G. (2022). Development and validation of RPLC method for the simultaneous analysis of ACE inhibitors in tablet formulations. Turkish Journal of Analytical Chemistry, Cilt: 4 - Sayı: 2, 103–110. https://ajindex.com/articles/870926

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. I. Maraj, J. N. Makaryus, A.Ashkar, S.I. McFarlane, A.N. Makaryus, Hypertension management in the high cardiovascular risk population, International Journal of Hypertension, 2013, 2013, 1-7.
  2. N.J. Brown, D.E. Vaughan, Angiotensin-converting enzyme inhibitors, Circulation, 97, 1998, 1411-1420.
  3. L. Brunton, B. Chabner, B. Knollman, Goodman and Gilman’s The Pharmacological Basis of Therapeutics (9. edition), 1996,
  4. New York, McGraw-Hill. R. Kumar, R. Sharma, K. Bairwa, R. Kumar Roy, A. Kumar, A. Baruwa, Modern development in ACE inhibitors, Der Pharmacia Lettre, 2(3), 2010, 388-419.
  5. B.G. Katzung, Basic & Clinical Pharmacology (12. edition), 2011,
  6. San Francisco, The McGraw-Hill Companies. S.D. Firke, K.R. Bhoi, K.R. Patil, S.D. Jayswal, A.R. Tekade, S.S. Chalikwar, A State-Of-The-Art Review on Applications of Different Analytical Techniques for Some ACE Inhibitors, Analytical Chemistry Letters, 10(1), 2020, 60-79.
  7. Y. Kazakevich, Y. Lobrutto, HPLC for Pharmaceutical Scientists (1. edition), 2007,
  8. Canada, Wiley-Interscience. V.R. Meyer, Practical High-Performance Liquid Chromatography (16. edition), 2010,
  9. United Kingdom, John Wiley and Sons, Ltd. Y.D. Daldal, E.Ç. Demiralay, S.A. Ozkan, Effect of organic solvent composition on dissociation constants of some reversible acetylcholinesterase inhibitors, Journal of the Brazilian Chemical Society, 27(3), 2016, 493-499.
  10. Y.D. Daldal, E.Ç. Demiralay, Chromatographic and UV–visible spectrophotometric pKa determination of some purine antimetabolites, Journal of Molecular Liquids, 317, 2020, 1-8.
  11. ICH, Validation of Analytical Procedures: Text and Methodology Q2 (R1) Harmonized Tripartite Guideline 2005.
  12. E.C. Demiralay, D. Koc, Y.D. Daldal, C. Cakır, Determination of Chromatographic and Spectrophotometric Dissociation Constants of Some Beta Lactam Antibiotics, Journal of Pharmaceutical and Biomedical Analysis, 71, 2012, 139– 143. E.Ç. Demiralay, Z. Üstün, Y.D. Daldal, Estimation of Thermodynamic Acidity Constants of Some Penicillinase-Resistant Penicillins, Journal of Pharmaceutical and Biomedical Analysis, 91, 2014, 7– 11. E.Ç. Demiralay, An Experimental Design Approach to Optimization of the Liquid Chromatographic Separation Conditions for the Determination of Metformin and Glibenclamide in Pharmaceutical Formulation, Acta Chimica Slovenica, 59(2), 2012, 307-314.
  13. T. Lundsted, E. Seifert, L. Abramo, B. Thelin, A. Nyström, J. Pettersen, R. Bergamn, Experimental Design and Optimization, Chemometrics and Intelligent Laboratory S